Danaher Corp. DHR

What this company does

Danaher operates through three segments—Biotechnology, Life Sciences and Diagnostics—comprising more than 15 operating companies with leadership positions in the biotechnology, life sciences and diagnostics sectors. As of December 31, 2025, the Company had approximately 60,000 employees. The Company's research and development, manufacturing, sales, distribution, service and administrative facilities are located in approximately 50 countries. The Biotechnology segment offers equipment, consumables, software and services used to advance and accelerate the research, development, manufacture and delivery of biological medicines. The Life Sciences segment offers instruments, consumables, services and software used to study the basic building blocks of life, including DNA, RNA, proteins, metabolites and cells, and to identify new therapies and test and manufacture new drugs, vaccines and gene editing technologies. The Diagnostics segment offers clinical instruments, consumables, software and services that hospitals, physicians' offices, reference laboratories and other critical care settings use to diagnose disease and make treatment decisions. Danaher originated in the early 1980s, when Steven M. and Mitchell P. Rales, who became the Company's founders, began building the business that grew into Danaher.

Written from the business description in DANAHER CORPORATION's annual report to the U.S. Securities and Exchange Commission, filed 24 February 2026. Every sentence was checked against that document before publication.